輸入代號或公司名稱後按 Enter
PBYI

PUMA BIOTECHNOLOGY, INC.

+0.15 (+1.60%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 製藥生技 · 製藥SIC 2834
9.54USD70.3K成交股數492M市值18.4本益比(近四季)2.1股價營收比+7.8%營收年增(近四季)2026-11-05下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營收56.5M+23%44.8M-24%54.5M-32%52.4M+11%46.0M+5%59.1M+5%80.5M+48%47.1M-11%43.8M56.1M54.6M52.8M
營業成本12.5M10.4M12.2M12.3M10.6M13.9M29.1M10.7M10.7M13.3M11.9M13.2M
毛利44.0M+24%34.4M-24%42.3M-18%40.1M+10%35.5M+7%45.2M+5%51.4M+20%36.4M-8%33.0M42.8M42.7M39.6M
毛利率77.9%76.7%77.7%76.5%77.1%76.4%63.9%77.4%75.5%76.3%78.3%75.0%
研發費用18.9M19.8M15.9M15.5M13.9M15.2M12.5M13.6M13.6M11.4M13.4M12.7M
銷售管理費用17.5M18.4M16.8M18.0M17.6M16.6M16.8M25.0M21.8M22.8M24.5M22.5M
營業利益7.6M+90%−3.8M-129%9.6M-57%6.6M-405%4.0M-273%13.4M+56%22.1M+351%−2.2M-150%−2.3M8.6M4.9M4.4M
營業利益率13.4%-8.5%17.6%12.7%8.7%22.6%27.4%-4.6%-5.3%15.3%9.0%8.3%
稅後淨利8.2M+175%−3.8M-119%8.8M-56%5.9M-229%3.0M-162%19.3M+233%20.3M+856%−4.5M-423%−4.8M5.8M2.1M1.4M
淨利率14.5%-8.4%16.2%11.2%6.5%32.7%25.2%-9.6%-11.0%10.3%3.9%2.7%
稀釋 EPS0.16+167%-0.07-118%0.17-59%0.12-233%0.06-160%0.40+233%0.41+720%-0.09-400%-0.100.120.050.03
稀釋股數52.6M50.8M50.9M50.1M49.9M49.1M49.2M48.3M48.2M47.8M47.2M47.2M

資產負債表 期末餘額

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
現金與約當現金36.5M36.2M53.5M54.7M63.0M69.2M67.3M67.1M76.8M81.8M60.0M61.4M
應收帳款34.1M26.3M33.6M25.9M25.2M32.0M54.6M28.1M24.6M29.0M31.3M31.2M
存貨13.3M8.7M9.5M8.6M8.8M8.7M2.7M9.0M7.1M5.7M7.6M3.9M
總資產193M193M203M195M196M213M221M205M214M204M200M196M
有息負債00010.9M10.6M21.7M32.7M43.7M54.7M76.6M87.6M98.6M
總負債54.2M64.3M87.6M90.2M99.1M121M150M156M163M165M170M170M
股東權益139M128M115M105M97.1M92.1M71.1M48.5M51.0M38.7M30.4M25.8M
負債比28.1%33.4%43.2%46.3%50.5%56.8%67.8%76.3%76.2%81.0%84.8%86.8%
淨現金(現金 − 有息負債)36.5M36.2M53.5M43.8M52.4M47.5M34.5M23.4M22.1M5.2M−27.6M−37.2M

現金流量表 單季

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營業現金流15.4M3.6M-68%11.2M2.6M
資本支出061K0
自由現金流15.4M3.6M-68%11.2M
折舊攤銷2.6M2.8M2.9M2.9M
買回庫藏股
現金股利
自由現金流率34.4%7.7%25.7%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

產品/服務2025 年度 · 228M
產品204M89.4%+4.6%
Royalty24.3M10.6%-31.1%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025228M-0.9%31.1M13.6%0.6141.7M
FY2024230M-2.2%30.3M13.1%0.6238.9M
FY2023236M+3.3%21.6M9.2%0.4526.9M
FY2022228M-9.9%2K0.0%0.00−15.8M
FY2021253M+12.5%29.1M11.5%-0.7220.7M
FY2020225M-17.3%−60.0M-26.7%-1.52727K
FY2019272M+8.5%−75.6M-27.8%-1.9522.1M
FY2018251M−114M-45.3%-2.99−24.5M